EL:NYE-Estee Lauder Companies Inc. (The) (USD)

EQUITY | Household & Personal Products | New York Stock Exchange

Last Closing

USD 154.15

Change

+9.11 (+6.28)%

Market Cap

USD 28.57B

Volume

4.85M

Analyst Target

USD 217.86
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

The Estee Lauder Companies Inc is engaged in the manufacturing & marketing of skin care, makeup, fragrance and hair care products.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-03-28 )

Largest Industry Peers for Household & Personal Products

Symbol Name Price(Change) Market Cap
PG Procter & Gamble Company

N/A

USD 373.23B
UL Unilever PLC ADR

N/A

USD 119.76B
CL Colgate-Palmolive Company

N/A

USD 73.02B
KMB Kimberly-Clark Corporation

N/A

USD 41.74B
CHD Church & Dwight Company Inc

N/A

USD 24.65B
CLX The Clorox Company

N/A

USD 18.11B
COTY Coty Inc

N/A

USD 9.98B
ELF ELF Beauty Inc

N/A

USD 8.70B
NTCO Natura & Co Holding SA

N/A

USD 4.63B
HIMS Hims Hers Health Inc

N/A

USD 2.99B

ETFs Containing EL

GDPY:CA Guardian Directed Premium.. 7.32 % 0.00 %

N/A

CAD 0.05B
GDPY-B:CA Guardian Directed Premium.. 7.32 % 0.00 %

N/A

CAD 0.13B
ASRV:XETRA BNP Paribas Easy ESG Euro.. 6.59 % 0.00 %

N/A

USD 0.06B
GDEP:CA Guardian Directed Equity .. 5.04 % 0.00 %

N/A

CAD 0.01B
GDEP-B:CA Guardian Directed Equity .. 5.04 % 0.00 %

N/A

CAD 0.05B
EUSR:LSE UBS(Lux)Fund Solutions .. 4.78 % 0.00 %

N/A

USD 0.11B
ESREUA:SW UBS(Lux)Fund Solutions .. 4.77 % 0.00 %

N/A

USD 0.90B
EMUSRI:SW UBS(Lux)Fund Solutions .. 4.56 % 0.00 %

N/A

USD 0.46B
EUSRS:SW UBS(Lux)Fund Solutions .. 4.56 % 0.00 %

N/A

USD 0.04B
EUSRT:SW UBS(Lux)Fund Solutions .. 4.56 % 0.00 %

N/A

USD 0.02B
EUSRU:SW UBS(Lux)Fund Solutions .. 4.56 % 0.00 %

N/A

USD 8.56M
JRNY ALPS Global Travel Benefi.. 4.31 % 0.00 %

N/A

USD 6.10M
C9DF:XETRA Frankfurter UCITS-ETF - M.. 4.08 % 0.00 %

N/A

N/A
HEAE:LSE SPDR® MSCI Europe Health.. 3.94 % 0.00 %

N/A

USD 0.64B
NBCC Neuberger Berman Next Gen.. 3.82 % 0.00 %

N/A

USD 5.43M
STWX:SW SPDR® MSCI Europe Health.. 3.77 % 0.00 %

N/A

USD 0.64B
SXDPEX:SW iShares STOXX Europe 600 .. 3.73 % 0.00 %

N/A

USD 0.44B
DIP ETF Series Solutions 3.53 % 0.00 %

N/A

USD 1.15M
UIW1:XETRA UBS(Lux)Fund Solutions .. 2.70 % 0.00 %

N/A

USD 0.21B
UIW2:XETRA UBS(Lux)Fund Solutions .. 2.70 % 0.00 %

N/A

USD 0.21B
UIW3:XETRA UBS(Lux)Fund Solutions .. 2.70 % 0.00 %

N/A

USD 0.21B
MOAT:AU VanEck Morningstar Wide M.. 2.58 % 0.00 %

N/A

USD 0.93B
MHOT:AU VanEck Morningstar Wide M.. 2.57 % 0.00 %

N/A

N/A
ZPW-U:CA BMO US Put Write ETF 2.12 % 0.00 %

N/A

N/A
OP2E:XETRA Ossiam Lux Ossiam MSCI EM.. 1.90 % 0.00 %

N/A

USD 0.39B
CEFA Global X S&P Catholic Val.. 1.90 % 0.00 %

N/A

USD 0.02B
TGED:CA TD Active Global Enhanced.. 0.00 % 0.00 %

N/A

CAD 0.27B
CACX:LSE Lyxor CAC 40 (DR) UCITS E.. 0.00 % 0.00 %

N/A

USD 3.66B
SCID 0.00 % 0.39 %

N/A

N/A
ZPW:CA BMO US Put Write ETF 0.00 % 0.71 %

N/A

CAD 0.06B
FLFR 0.00 % 0.09 %

N/A

N/A
HLTH:LSE SPDR® MSCI Europe Health.. 0.00 % 0.00 %

N/A

USD 0.18M
XSDR:LSE Xtrackers MSCI Europe Hea.. 0.00 % 0.00 %

N/A

USD 0.14B
CAC:PA Lyxor UCITS CAC 40 (DR) D.. 0.00 % 0.00 %

N/A

USD 3.47B
CACC:PA Lyxor CAC 40 (DR) UCITS E.. 0.00 % 0.00 %

N/A

USD 0.26B
STW:PA SPDR® MSCI Europe Health.. 0.00 % 0.00 %

N/A

USD 0.64B
C068:F 0.00 % 0.00 %

N/A

N/A
DXSE:F Xtrackers Stoxx Europe 60.. 0.00 % 0.00 %

N/A

USD 0.14B
ELFB:F Deka Oekom Euro Nachhalti.. 0.00 % 0.00 %

N/A

USD 0.23B
EXV4:F iShares STOXX Europe 600 .. 0.00 % 0.00 %

N/A

USD 0.69B
LESE:F 0.00 % 0.00 %

N/A

N/A
SPYH:F SSgA SPDR ETFs Europe II .. 0.00 % 0.00 %

N/A

USD 0.64B
UIMR:F UBS (Lux) Fund Solutions .. 0.00 % 0.00 %

N/A

USD 0.90B
C068:XETRA 0.00 % 0.00 %

N/A

N/A
DXSE:XETRA Xtrackers - Stoxx Europe .. 0.00 % 0.00 %

N/A

USD 0.14B
ELFB:XETRA Deka Oekom Euro Nachhalti.. 0.00 % 0.00 %

N/A

USD 0.23B
EXV4:XETRA iShares STOXX Europe 600 .. 0.00 % 0.00 %

N/A

USD 0.70B
LESE:XETRA 0.00 % 0.00 %

N/A

N/A
SPYH:XETRA SPDR® MSCI Europe Health.. 0.00 % 0.00 %

N/A

USD 0.66B
UIMR:XETRA UBS (Lux) Fund Solutions .. 0.00 % 0.00 %

N/A

USD 0.79B
3SUE:XETRA iShares MSCI World Consum.. 0.00 % 0.00 %

N/A

USD 0.09B
UB39:LSE UBS(Lux)Fund Solutions .. 0.00 % 0.00 %

N/A

USD 0.92B
ESIH:LSE iShares MSCI Europe Healt.. 0.00 % 0.00 %

N/A

USD 0.58B
ESIH:F Ishares VI PLC - Ishares .. 0.00 % 0.00 %

N/A

USD 0.58B
ESIH:XETRA iShares MSCI Europe Healt.. 0.00 % 0.00 %

N/A

USD 0.58B
XZEZ:XETRA Xtrackers MSCI EMU ESG UC.. 0.00 % 0.00 %

N/A

USD 0.06B
EURSRI:SW UBS(Lux)Fund Solutions .. 0.00 % 0.00 %

N/A

USD 0.13B
XZEZ:SW Xtrackers MSCI EMU ESG UC.. 0.00 % 0.00 %

N/A

USD 0.06B

Market Performance

  Market Performance vs. Industry/Classification (Household & Personal Products) Market Performance vs. Exchange (New York Stock Exchange)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 5.40% 44% F 58% F
Dividend Return 0.45% 31% F 28% F
Total Return 5.85% 39% F 57% F
Trailing 12 Months  
Capital Gain -37.52% 17% F 6% D-
Dividend Return 1.07% 8% B- 13% F
Total Return -36.45% 17% F 6% D-
Trailing 5 Years  
Capital Gain -6.89% 38% F 36% F
Dividend Return 6.51% 25% F 22% F
Total Return -0.37% 31% F 27% F
Average Annual (5 Year Horizon)  
Capital Gain 2.50% 53% F 52% F
Dividend Return 3.38% 42% F 46% F
Total Return 0.88% 20% F 24% F
Risk Return Profile  
Volatility (Standard Deviation) 36.59% 53% F 29% F
Risk Adjusted Return 9.23% 37% F 36% F
Market Capitalization 28.57B 83% B 95% A

Key Financial Ratios

  Ratio vs. Industry/Classification (Household & Personal Products) Ratio vs. Market (New York Stock Exchange)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 26.50 19% 5%
Price/Book Ratio 9.34 28% 8%
Price / Cash Flow Ratio 30.82 18% 8%
Price/Free Cash Flow Ratio 30.73 17% 6%
Management Effectiveness  
Return on Equity 7.27% 44% 46%
Return on Invested Capital 9.08% 59% 62%
Return on Assets 2.91% 33% 55%
Debt to Equity Ratio 127.43% 31% 26%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Highly leveraged

The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.

Poor return on assets

The company management has delivered below median return on assets in the most recent 4 quarters compared to its peers.

Poor return on equity

The company management has delivered below median return on equity in the most recent 4 quarters compared to its peers.

Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Low Earnings Growth

This stock has shown below median earnings growth in the previous 5 years compared to its sector

Low Revenue Growth

This stock has shown below median revenue growth in the previous 5 years compared to its sector

Low Dividend Growth

This stock has shown below median dividend growth in the previous 5 years compared to its sector.